Hyper-CL™:
An innovative therapeutic contact lens.
Hyper-CL™ Therapeutic Soft Contact Lens’s unique design protects the cornea, improving treatment. Hyper-CL™ is indicated for various corneal conditions as well as post-surgical conditions and is clinically proven to relieve corneal pathologies, significantly increasing the quality of life. Hyper-CL™ is FDA Cleared-for daily wear and is in the commercialization stage across Europe and Asia.
The Need
The Hyper-CL™ Therapeutic Soft Contact Lens is intended for daily use to promote corneal healing and relieve corneal pain by protecting the cornea during the treatment of acute or chronic pathologies such as corneal edema, corneal erosions, entropion, bullous keratopathy, and corneal dystrophies, as well as post-surgical conditions resulting from cataract extraction and corneal surgery. Hyper-CL™ Therapeutic Soft Contact Lenses can even provide optical correction during healing, if required.
Hyper CL® - designed to deliver
Hyper CL protects and cures the cornea
Relief Pain
With its unique design, Hyper-CL™ contact lens, the Hyper CL found to facilitate healing.
Applied like other contact lenses
Hyper-CL™ therapeutic lens is easy to wear, clean, and remove as any other contact lens
Shields the eye
Adding another layer of protection, Hyper-CL™ therapeutic lens protects the eye, acting as a buffer from the eyelid and allowing for better healing.
Clinical studies
Therapeutic HL-Contact Lens versus Standard Bandage Contact Lens for Corneal Edema: A Prospective, Multicenter, Randomized, Crossover Study
To compare the safety and efficacy of the Therapeutic Hyper-CL™ lens versus a standard bandage contact lens (PureVision B&L) for chronic corneal edema.
Download
Prof. Francis Mah, MD, San Diego, CA, USA
I was able to try the Hyper-CL™ in a patient with a corneal melt, significant corneal edema, and Serratia infectious keratitis. The result was dramatic. The patient had resolution within a week with complete resolution of the patient’s AC inflammation/hypopyon. The epithelium was completely healed, and the infiltrate was almost completely resolved. Usually, these are long courses that take an average of 2 weeks to resolve.
Prof. Lional Raj, MD, Tirunelveli, India
The concept of using a novel drug repository contact lens is effective in prolonging corneal antimicrobial availability and drug contact time over the lesion and has demonstrated faster corneal healing, which may affect the overall outcomes in bacterial keratitis. Using a drug depo contact lens, may reduce the regimen of antibiotics, decrease treatment burden on the medical staff, improve patient tolerance, and reduce toxicities.
Prof. Irit Barequet, MD, Sheba Medical Center, Israel
The proportion of patients achieving a significant improvement in CCT and BCVA was greater in the therapeutic Hyper-CL™ group. In addition, the therapeutic Hyper-CL™ group had a greater improvement in mean BCVA and mean CCT.
Dr Boris Knyazer MD, Soroka Medical Center
Upon Hyper CL™ insertion, as well as hyperosmotic saline application, patients were extremely surprised to find a significant sight improvement, emphasizing the high level of excitement and significance those patients were experiencing.
Dr. Moshe Mendelson, Silicon Valley Eye Physicians
Excellent results for our first patient. Patient and I satisfied with outcome. His Visual acuity improved from 20/200- to 20/60+.
Dr. Navneet Toshniwal, India
I used lens for bullous keratopathy with excellent result. Corneal condition improves and then visual acuity too. I am excited to use more.
